Listing 3 - Actual negotiations

Indication:

Basal Cell Carcinoma (BCC), locally advanced in adult patients with histologically confirmed laBCC that is not amenable to radiation therapy or curative surgery

Indication:

Multiple Myeloma (Relapsed)

Indication:

Cystic Fibrosis In Patients with CFTR Gating Mutations or the R117H Gating Mutation

Indication:

Cystic Fibrosis, F508del CFTR mutation

Indication:

Deep vein thrombosis (treatment and prevention)

Indication:

Minimal Residual Disease (MRD)-Positive B-Cell Precursor Acute Lymphoblastic Leukemia (BCP ALL)

Indication:

Rheumatoid Arthritis

Indication:

Psoriasis, moderate to severe plaque

Indication:

Hodgkin's Lymphoma

Indication:

Primary Cutaneous Anaplastic Large Cell Lymphoma (or CD30- Expressing Mycosis Fungoides)